Corcept Therapeutics

CORT

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitiga …

Insider trades and stock quote 2020-2022

All insider trades at Corcept Therapeutics

Subscribe RSS
DateTypeInsiderPositionØ-PriceVolume
5/19/2022 SellRobb, Gary Charles Chief Business Officer $19.6 $119,928
5/18/2022 SellRobb, Gary Charles Chief Business Officer $19.6 $2,502
5/17/2022 SellRobb, Gary Charles Chief Business Officer $19.6 $561,965
3/18/2022 SellRobb, Gary Charles Chief Business Officer $24.7 $123,054
3/17/2022 SellRobb, Gary Charles Chief Business Officer $24.7 $185,374
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)